SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

HealthFore Technologies Ltd (533525)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 533525 NSE: IT - Software | Small Cap | HealthFore Tech Share Price

BSE Share Price
Not Listed

HealthFore Technologies Ltd (533525)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 533525 NSE: IT - Software | Small Cap | HealthFore Tech Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹5 Cr.
Current Price
₹0
52-Week Low / High
₹7 / 7
TTM EPS
₹1.2
TTM Sales
₹11.3 Cr.
Book Value per Share
₹-653.2
P/E Ratio
5.53
Industry PE
21.5
Price to Book (P/B)
-0.01
Price to Sales (P/S)
0.48
EV/EBITDA
-1547.52
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
0.00%
Return on Capital Employed (ROCE)
-16.76%
Return on Assets (ROA)
-89.11%
Operating Profit Margin
-19.8%
Net Profit Margin
-514.07%
Gross Profit Margin
-479.5%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
-5.72%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
49.44%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹-525 Cr.
Equity
₹8.1 Cr.
Face Value
₹10
All Time Low / High
₹5.89 / 90.00

HealthFore Technologies stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17TTM
ROCE % 0%0%0%-120.7%-17%-14%-31.7%2.1%-5.3%-16.8%-

Growth Parameters

Sales 0012593.561.921.227.319.818.417.311
Sales YoY Gr.-NANA-25.3%-33.8%-65.7%28.4%-27.2%-7.4%-5.7%-
Adj EPS 00-49.7-86.2-87.8-83.5-80.5-74.4-90.9-109.31.2
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 00-53.1-139.4-229.1-312.6-406.1-483.3-571.2-683.7-653.2
Adj Net
Profit
00-40.4-70.1-71.4-67.9-65.4-60.5-73.9-88.91
Cash Flow from Ops. 0054.6-73.2-30.1-15.39.4-48.959.864.9-
Debt/CF from Ops. 000.6-2.9-13-20.741.2-10.48.99.1-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA-22.5%-14%-5.7%
Adj EPS NANANANA
BVPSNANANANA
Share Price - - - -

Key Financial Parameters

Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17TTM
Return on
Equity %
0093.789.647.730.822.817.317.817.9-0.2
Op. Profit
Mgn %
00-24.7-46.3-45.2-93.3-36.5-9.6-20.8-19.8-20.8
Net Profit
Mgn %
00-32.3-75-115.3-319.8-240.1-305.1-402.5-513.48.6
Debt to
Equity
00-0.8-1.8-2.1-1.2-1.2-1.3-1.1-1.1-
Working Cap
Days
0002407531,9795461,2281,410936512
Cash Conv.
Cycle
0006299162103194242220-9,400

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17
Sales125.1793.5261.9221.2227.2519.8318.3617.31
Operating Expenses > + 156.30136.9792.4841.1037.6121.8922.2320.89
Manufacturing Costs6.394.071.680.560.470.292.714.47
Material Costs73.0833.2216.831.612.76000
Employee Cost 52.0662.1845.4521.9320.0812.5311.959.42
Other Costs > 24.7737.5028.5117.0114.319.077.577.01
Operating Profit > -31.13-43.44-30.56-19.88-10.36-2.06-3.87-3.59
Operating Profit Margin (%) -24.9%-46.5%-49.4%-93.7%-38.0%-10.4%-21.1%-20.7%
Other Income > + 1.713.0921.8813.774.3611.634.671.33
Exceptional Items > 00000000
Interest > 6.7917.5147.3049.1346.9361.3868.7980.74
Depreciation > 4.2212.3016.9512.6512.647.795.615.98
Profit Before Tax > -40.43-70.17-72.93-67.89-65.57-59.60-73.60-88.97
Tax > 0.140000000
Profit After Tax -40.57-70.17-72.93-67.89-65.57-59.60-73.60-88.97
PAT Margin (%) -32.4%-75.0%-117.0%-319.0%-240.0%-300.0%-400.0%-514.0%
Adjusted EPS (₹)-49.9-86.3-89.7-83.5-80.7-73.3-90.5-109.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%

Valuation of HealthFore Tech - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17

Equity and Liabilities

Shareholders Fund + -43.13-113.30-186.23-254.12-319.69-379.47-453.09-542.05
Share Capital 8.138.138.138.138.138.138.138.13
Reserves -51.26-121.43-194.36-262.25-327.82-387.60-461.21-550.18
Debt +35.01198.05384.99316.17374.69485.29482.03524.79
Long Term Debt35.01159.38107.810188.89266.67219.67164.17
Short Term Debt038.67277.18316.17185.80218.63262.36360.62
Minority Interest00000000
Trade Payables28.026.091.490.951.250.630.073.21
Others Liabilities 77.1734.7028.9216.0928.6740.2869.16115.56
Total Liabilities 97.07125.54229.1779.0884.92146.7398.17101.51

Fixed Assets

Net Fixed Assets +38.0444.9730.4616.3313.3532.3538.0932.49
Gross Block44.1962.8461.6957.8356.8477.3676.5476.05
Accumulated Depreciation6.1517.8631.2341.5043.5045.0138.4643.56
CWIP 0.162.135.1914.5415.080.01011.50
Investments 3.093.093.093.094.41000
Inventories3.862.921.6500000
Trade Receivables30.2422.6211.856.7810.2812.5212.4411.18
Cash Equivalents 1.126.983.601.853.415.682.241.57
Others Assets 20.5642.83173.3336.4938.4096.1745.4144.77
Total Assets 97.07125.54229.1779.0884.92146.7398.17101.51

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17
Cash Flow From Operating Activity + 54.64-73.16-30.10-15.259.37-48.9459.7764.91
PBT -40.43-70.17-72.93-67.89-65.57-59.60-73.60-88.97
Adjustment 13.6737.4245.2956.9459.0661.0970.3285.73
Changes in Working Capital 81.48-40.41-2.46-4.315.88-50.4263.0568.14
Tax Paid -0.08-0000000
Cash Flow From Investing Activity + -29.52-21.85-112.80137.02-16.37-9.33-7.96-11.43
Capex -27.47-19.28-51.33-10.61-12.08-11.38-11.89
Net Investments -3.09000-1.234.610.020
Others 1.05-2.57-107.80135.68-4.53-1.873.400.47
Cash Flow From Financing Activity + -25.40100.87139.52-123.518.9357.09-52.01-55.17
Net Proceeds from Shares 0.050000000
Net Proceeds from Borrowing 00000000
Interest Paid -7.02-14.55-43.99-47.50-60.71-58.07-66.19-102.48
Dividend Paid 00000000
Others -18.42115.42183.51-76.0169.64115.1614.1847.30
Net Cash Flow -0.275.87-3.39-1.741.93-1.18-0.20-1.69

Financial Ratio

PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17
Ratios
ROE (%)N/AN/AN/AN/AN/AN/AN/AN/A
ROCE (%)N/AN/AN/AN/AN/AN/AN/AN/A
Asset Turnover Ratio1.290.840.350.140.330.170.150.17
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days88.20103.20101.60160.20114.30209.80248.10249
Inventory Days11.3013.2013.5000000
Payable Days139.90187.4082.10276.60145.80000

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

HealthFore Technologies Ltd FAQs

The current trading price of HealthFore Tech on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of HealthFore Tech stood at ₹5.40 Cr

The latest P/E ratio of HealthFore Tech as of 31-Dec-1969 is 5.53.

The latest P/B ratio of HealthFore Tech as of 31-Dec-1969 is -0.01.

The 52-week high of HealthFore Tech is ₹6.64 and the 52-week low is ₹6.64.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of HealthFore Tech is ₹11.31 ( Cr.) .

Data is not available for this company.

No data found

No data found

About HealthFore Technologies Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×